Caleb Rojas is a Miami, Florida based male eyecare provider who is specialized as Optician. He has professional credentials of DO. Active license number of Caleb Rojas is 4388 for Optician in Florida. Caleb Rojas makes / sells eyeglasses and, contact lenses, for remedying defects of vision in accordance with the prescriptions of ophthalmologists and optometrists. Opticians also specializes in filling lens prescriptions, assisting patients with lens and frame selection and fitting (including style, weight and colour) but they do not test vision or write prescriptions for visual correction.
Complete Profile:
Caleb Rojas speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Optician
Credentials:
DO
Gender:
Male
Practice Address:
6050 Sw 45th St, Miami, Florida, 33155-6060
Phone:
305-972-7771
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1093593584
NPI Enumeration Date:
18 Sep, 2023
NPI Last Update On:
18 Sep, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Caleb Rojas are as mentioned below.
License Number
Specialization
State
Status
4388
Optician
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
6050 Sw 45th St, Miami, Florida
Zip:
33155-6060
Phone Number:
305-972-7771
Fax Number:
--
Patients can reach Caleb Rojas at 6050 Sw 45th St, Miami, Florida or can call to book an appointment on 305-972-7771. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.